James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why Best Buy Co Inc (BBY), American Eagle Outfitters (AEO) and Palo Alto Networks Inc (PANW) Are 3 of Today’s Worst Stocks

Last quarter's earnings reports American Eagle Outfitters (AEO), Palo Alto Networks (PANW) and Best Buy (BBY) were their undoing on Wednesday.

Why BP plc (ADR) (BP) Stock MIGHT Be Worthy Again

Saddled by debt and performing poorly, BP stock is tough to own right now. North Africa, though, is a bright spot that could salvage the stock.

JD.Com Inc(ADR) Stock Still Has a Lot of Long-Term Oomph

JD stock is up 20% since the end of 2016, and for good reason. But JD.com is still miles away from the being the end of the saga.

Why Charles Schwab Corp (SCHW), Valeant Pharmaceuticals Intl Inc (VRX) and Perrigo Company plc Ordinary Shares (PRGO) Are 3 of Today’s Worst Stocks

Valeant Pharmaceuticals (VRX), Perrigo Company (PRGO) and Charles Schwab (SCHW) were all doomed from the start of Tuesday's trading action.

Target Corporation (TGT) Stock Is Even Worse Than Q4 Earnings Suggest

Target (TGT) fell sharply following its Q4 earnings release, but the story behind TGT stock might be even worse than the raw numbers.